Dudediligence.

Liquidia Corporation

LQDANASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$136.4M

36 notices · 2,627,366 sh

Oct 2025 to Oct 2026

Reported ·

$165.7M

131 sales · 1 buy · $317,894 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

78 of 131 reported sales carry the 10b5-1 box. Together they are 3.53% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-14: RAMANDEEP SINGH, Form 1442026-09-11: RAMANDEEP SINGH, Form 1442026-08-21: JASON ADAIR, Form 1442026-08-19: Katherine T. Rielly-Gauvin, Form 1442026-08-19: RAJEEV SAGGAR, Form 1442026-08-17: RAJEEV SAGGAR, Form 1442026-06-11: SARAH KREPP, Form 1442026-06-10: Canaan VIII LP, Form 1442026-06-08: Canaan VIII LP, Form 1442026-06-04: Canaan VIII LP, Form 1442026-06-04: Paul B Manning, Form 1442026-06-01: KIRSCH ARTHUR S, Form 1442026-05-21: RAMANDEEP SINGH, Form 1442026-05-20: SERENDIPITY BIOPHARMA LLC, Form 1442026-05-14: SERENDIPITY BIOPHARMA LLC, Form 1442026-05-11: Canaan VIII LP, Form 1442026-05-08: SERENDIPITY BIOPHARMA LLC, Form 1442026-05-07: SERENDIPITY BIOPHARMA LLC, Form 1442026-04-17: SERENDIPITY BIOPHARMA LLC, Form 1442026-04-16: SERENDIPITY BIOPHARMA LLC, Form 1442026-04-15: SERENDIPITY BIOPHARMA LLC, Form 1442026-04-15: MICHAEL KASETA, Form 1442026-04-14: MICHAEL KASETA, Form 1442026-04-10: SERENDIPITY BIOPHARMA LLC, Form 1442026-04-10: MICHAEL KASETA, Form 1442026-04-09: SERENDIPITY BIOPHARMA LLC, Form 1442026-04-09: MICHAEL KASETA, Form 1442026-03-27: Canaan VIII LP, Form 1442026-03-26: Canaan VIII LP, Form 1442026-03-13: RAMANDEEP SINGH, Form 1442026-03-13: Rajeev Saggar, Form 1442026-03-13: SARAH T KREPP, Form 1442026-03-09: SCOTT MOOMAW, Form 1442025-11-18: JASON ADAIR, Form 1442025-11-07: Dana Boyle, Form 1442025-11-05: Rajeev Saggar, Form 1442025-10-13: Krepp Sarah, sold2025-10-13: Adair Jason, sold2025-10-13: JEFFS ROGER, sold2025-10-13: Boyle Dana, sold2025-10-13: Saggar Rajeev, sold2025-10-13: Moomaw Scott, sold2025-10-13: Kaseta Michael, sold2025-10-13: Schundler Russell, sold2025-10-27: Boyle Dana, sold2025-10-27: Adair Jason, sold2025-11-05: Saggar Rajeev, sold2025-11-07: Boyle Dana, sold2025-11-18: Adair Jason, sold2025-12-01: Moomaw Scott, sold2025-12-01: Adair Jason, sold2025-12-01: Boyle Dana, sold2025-12-01: Kaseta Michael, sold2025-12-01: Krepp Sarah, sold2025-12-01: Schundler Russell, sold2026-01-12: Saggar Rajeev, sold2026-01-12: Boyle Dana, sold2026-01-12: JEFFS ROGER, sold2026-01-12: Schundler Russell, sold2026-01-12: Adair Jason, sold2026-01-12: Kaseta Michael, sold2026-01-12: Moomaw Scott, sold2026-01-12: Krepp Sarah, sold2026-01-26: Adair Jason, sold2026-01-26: Boyle Dana, sold2026-03-02: Adair Jason, sold2026-03-02: Boyle Dana, sold2026-03-02: Kaseta Michael, sold2026-03-02: Krepp Sarah, sold2026-03-02: Moomaw Scott, sold2026-03-02: Schundler Russell, sold2026-03-09: Moomaw Scott, sold2026-03-13: SINGH RAMAN, sold2026-03-13: Krepp Sarah, sold2026-03-13: Saggar Rajeev, sold2026-03-23: Moomaw Scott, sold2026-03-26: Bloch Stephen M, sold2026-04-09: Kaseta Michael, sold2026-04-09: JEFFS ROGER, sold2026-04-10: JEFFS ROGER, sold2026-04-10: Kaseta Michael, sold2026-04-13: Schundler Russell, sold2026-04-13: Saggar Rajeev, sold2026-04-13: Krepp Sarah, sold2026-04-13: Boyle Dana, sold2026-04-13: Adair Jason, sold2026-04-13: Moomaw Scott, sold2026-04-14: Kaseta Michael, sold2026-04-14: JEFFS ROGER, sold2026-04-17: JEFFS ROGER, sold2026-04-27: Adair Jason, sold2026-04-27: Boyle Dana, sold2026-05-05: JEFFS ROGER, sold2026-05-08: JEFFS ROGER, sold2026-05-11: Bloch Stephen M, sold2026-05-13: JEFFS ROGER, sold2026-05-18: JEFFS ROGER, sold2026-05-19: Caligan Partners LP, sold2026-05-19: Caligan Partners LP, bought2026-05-21: JEFFS ROGER, sold2026-05-21: SINGH RAMAN, sold2026-05-27: JEFFS ROGER, sold2026-06-01: KIRSCH ARTHUR S, sold2026-06-01: Krepp Sarah, sold2026-06-04: Bloch Stephen M, sold2026-06-04: Manning Paul B, sold2026-06-08: Bloch Stephen M, sold2026-06-08: Khindri Sanjeev, sold2026-06-10: Bloch Stephen M, sold2026-06-11: Krepp Sarah, sold2026-06-12: Bloch Stephen M, sold2026-06-22: Bloch Stephen M, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-14RAMANDEEP SINGH, Director$560,243
8,468 shno plan dateForm 4s on file end Jun 23144 ↗
2026-09-11RAMANDEEP SINGH, Director$619,210
9,024 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-21JASON ADAIR, Chief Business Officer$5,231,483
73,631 shplan 2026-05-22Form 4s on file end Jun 23144 ↗
2026-08-19Katherine T. Rielly-Gauvin, Director$4,101,678
55,182 shplan 2026-05-20Form 4s on file end Jun 23144 ↗
2026-08-19RAJEEV SAGGAR, Chief Medical Officer$3,702,825
50,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-17RAJEEV SAGGAR, Chief Medical Officer$2,269,381
29,534 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-11SARAH KREPP, Chief Human Resource Officer$1,623,420
24,880 shplan 2026-03-12144 ↗
Form 4, 2026-06-15: sold 24,880 at $70.28 Form 4 ↗
2026-06-10Canaan VIII LP, Director$13.0M
200,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-08Canaan VIII LP, Director$12.8M
200,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-04Canaan VIII LP, Director$13.0M
200,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-04Paul B Manning, Director$11.1M
200,000 shno plan date144 ↗
Form 4, 2026-06-08: sold 200,000 at $63.91 Form 4 ↗
2026-06-01KIRSCH ARTHUR S, Director$1,841,100
30,000 shno plan date144 ↗
Form 4, 2026-06-03: sold 30,000 at $57.71 Form 4 ↗
2026-05-21RAMANDEEP SINGH, Director$1,773,437
29,494 shno plan date144 ↗
Form 4, 2026-05-26: sold 29,494 at $60.13 Form 4 ↗
2026-05-20SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$6,383,551
106,428 shplan 2025-11-05144 ↗
Form 4, 2026-05-26: sold 75,000 at $61.01 Form 4 ↗
2026-05-14SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$5,759,000
100,000 shplan 2025-11-05144 ↗
Form 4, 2026-05-20: sold 75,000 at $58.91 Form 4 ↗
2026-05-11Canaan VIII LP, Director$15.9M
318,893 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-08SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$4,228,000
100,000 shplan 2025-11-05144 ↗
Form 4, 2026-05-12: sold 75,000 at $45.89 Form 4 ↗
2026-05-07SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$1,053,500
25,000 shplan 2025-11-05Form 4s on file end Jun 23144 ↗
2026-04-17SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$2,849,935
68,839 shplan 2025-11-05144 ↗
Form 4, 2026-04-21: sold 18,839 at $40.60 Form 4 ↗
2026-04-16SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$1,003,000
25,000 shplan 2025-11-05Form 4s on file end Jun 23144 ↗
2026-04-15SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$957,414
24,733 shplan 2025-11-05Form 4s on file end Jun 23144 ↗
2026-04-15MICHAEL KASETA, CFO and COO$5,395,787
139,390 shplan 2025-11-05Form 4s on file end Jun 23144 ↗
2026-04-14MICHAEL KASETA, CFO and COO$116,550
3,000 shplan 2025-11-05144 ↗
Form 4, 2026-04-16: sold 142,390 at $40.14 Form 4 ↗
2026-04-10SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$1,008,000
25,000 shplan 2025-11-05144 ↗
Form 4, 2026-04-14: sold 54,177 at $39.06 Form 4 ↗
2026-04-10MICHAEL KASETA, CFO and COO$960,463
23,821 shplan 2025-11-05144 ↗
Form 4, 2026-04-14: sold 42,779 at $39.36 Form 4 ↗
2026-04-09SERENDIPITY BIOPHARMA LLC, Chief Executive Officer$954,750
25,000 shplan 2025-11-05144 ↗
Form 4, 2026-04-13: sold 25,000 at $40.12 Form 4 ↗
2026-04-09MICHAEL KASETA, CFO and COO$5,109,402
133,789 shplan 2025-11-05144 ↗
Form 4, 2026-04-13: sold 133,789 at $40.24 Form 4 ↗
2026-03-27Canaan VIII LP, Board Member$2,100,000
62,550 shno plan dateForm 4s on file end Jun 23144 ↗
2026-03-26Canaan VIII LP, Board Member$285,000
7,684 shno plan dateForm 4s on file end Jun 23144 ↗
2026-03-13RAMANDEEP SINGH, Director$1,457,297
40,359 shno plan date144 ↗
Form 4, 2026-03-17: sold 20,000 at $36.04 Form 4 ↗
2026-03-13Rajeev Saggar, Chief Medical Officer$1,283,834
35,365 sh10b5-1 plan144 ↗
Form 4, 2026-03-17: sold 35,365 at $36.30 Form 4 ↗
2026-03-13SARAH T KREPP, Chief Human Resource Officer$617,918
16,261 shplan 2026-03-12144 ↗
Form 4, 2026-03-17: sold 16,261 at $38.00 Form 4 ↗
2026-03-09SCOTT MOOMAW, Chief Commercial Officer$3,603,000
100,000 shplan 2025-11-07144 ↗
Form 4, 2026-03-11: sold 80,000 at $35.32 Form 4 ↗
2025-11-18JASON ADAIR, Chief Business Officer$1,012,630
35,656 shplan 2025-05-29144 ↗
Form 4, 2025-11-20: sold 35,656 at $30.03 Form 4 ↗
2025-11-07Dana Boyle, Chief Accounting Officer$727,581
29,004 sh10b5-1 plan144 ↗
Form 4, 2025-11-12: sold 29,004 at $25.09 Form 4 ↗
2025-11-05Rajeev Saggar, Chief Medical Officer$1,927,287
71,381 sh10b5-1 plan144 ↗
Form 4, 2025-11-07: sold 71,381 at $27.00 Form 4 ↗